DAN STOKELY - 25 Jun 2021 Form 4 Insider Report for Ampio Pharmaceuticals, Inc.

Role: CFO
Signature: /s/ Daniel Stokely
Issuer symbol: N/A
Transactions as of: 25 Jun 2021
Net transactions value: -$30,600
Form type: 4
Filing time: 29 Jun 2021, 11:22:40 UTC
Previous filing: 19 May 2021
Next filing: 13 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMPE	Common Stock	Options Exercise	$9,675	+22,500	+79%	$0.4300	50,815	25 Jun 2021	Direct
transaction	AMPE	Common Stock	Sale	$40,275	-22,500	-44%	$1.79	28,315	25 Jun 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMPE	1. Stock Option (Right to Buy)	Options Exercise	$0	-22,500	-8%	$0.000000	260,500	25 Jun 2021	Common Stock	22,500	$0.4300	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Options were previously reported on a Form 4 dated August 22, 2019, where 50% of the stock option award vested and became exercisable on the date of grant, and the remaining 50% of the stock option award vested and became exercisable on July 31, 2020.